FDA, NIH officials look to curb animal testing in drug development
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyCBERCDERPharmaceuticalsPreclinicalPreclinical studyProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)